June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Effect of Surfactant Protein A on Vascular Function and Gene Profiling In Human Retinal Endothelial Cells
Author Affiliations & Notes
  • Faizah N Bhatti
    Ped Neonatal Med/Ophthal, Univ of Oklahoma Hlth Sci Ctr, Oklahoma City, OK
  • Annette Linens
    Ped Neonatal Med/Ophthal, Univ of Oklahoma Hlth Sci Ctr, Oklahoma City, OK
  • Footnotes
    Commercial Relationships Faizah Bhatti, None; Annette Linens, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 953. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Faizah N Bhatti, Annette Linens; Effect of Surfactant Protein A on Vascular Function and Gene Profiling In Human Retinal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):953.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We have previously shown that Surfactant protein A (SP-A) SP-A modulates human retinal endothelial cell function in vitro and showed a decrease in neovascularization in SP-A-/- mice in the oxygen induced retinopathy (OIR) model. We hypothesize that SP-A decreases inflammatory signals and alters the expression of angiogenic factors in retinal microvascular endothelial cells. In order to test this hypothesis, human retinal endothelial cells (HREC’s) in culture were treated with purified human SP-A (hSP-A) protein. Expression of angiogenic and inflammatory mediators was then tested by real time Profiler PCR array.

Methods: HREC's were cultured and then treated with either 10 ug/ml of human purified SP-A protein (hSP-A) or control media for 6 hours. HREC function was then quantified using migration, proliferation and tube formation assays. RT-PCR array was then performed on the SP-A treated HREC's for 84 angiogenesis specific genes.<br />

Results: HREC proliferation, migration and tube formation were significantly impaired after treatment with SP-A. After RT-PCR, genes were divided into three groups, those with an increase, decrease and the third group with no significant change. Genes with significant increases included: EPH receptor B4, Chemokine ligand 11, Endoglin, Collagen type XVIII, α1 and Cadherin 5, type 2 [vascular endothelium]. Genes with significant decrease included the following: Interleukin 8; Epidermal growth factor; Plasminogen activator, urokinase; TIMP metallopeptidase inhibitor 1. Gene pathways were arranged into three major categories: related to endothelial cell function, inflammation and oxidative stress. Surprisingly, specific well known genes involved in angiogenesis and oxygen induced damage were not changed e.g., VEGF-A, VEGF-B, VEGF-C, Hif1-alpha and Notch 4.

Conclusions: This data shows that several novel pathways are involved in the signaling pathways involving SP-A mediated changes in blood vessel growth and neovascularization. These pathways now need further elucidation and study to determine where SP-A function may be altered early enough in order to protect against the development of neovascularization in ROP.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×